In an era where healthcare increasingly intersects with digital technology, Nik Pooviah and his San Diego-based company, Elly, are transforming how chronic conditions are managed. With a mission to improve patient outcomes and quality of life through AI-driven tools, Elly is at the forefront of digital health innovation. In a recent conversation with Pooviah, we gained insight into the company’s achievements, future vision, and the challenges faced by health tech startups in navigating complex policy landscapes.

Elly’s Digital Health Revolution

Nik Pooviah, along with his co-founder Simon Holland, developed Elly to help the growing population of patients dealing with chronic diseases. Their creation, a smart audio companion named “Elly,” is designed to comfort, educate, and support patients through their health journeys. “Our objective with the product is to improve patients being activated in their own health, to give them the tools and support in a unique way through a friendly voice,” said Pooviah.

Elly’s approach to patient care is rooted in personalized, AI-driven engagement. With over 2,000 voice recordings covering topics such as motivation, meditation, and sleep, Elly provides tailored content based on a patient’s symptoms, diagnosis, and emotional needs. This personalized care has already made a significant impact. Pooviah shared that, in clinical studies, cancer patients using the Elly app experienced a 15% improvement in their quality of life within just 30 days.

Digital Tools and AI Integration

While Elly is an advanced digital tool today, Pooviah discussed plans to integrate more sophisticated AI technologies in the near future. “We are starting to explore conversational AI with Elly, thinking about how patients can talk to Elly and receive support in a sophisticated way,” he noted. Elly’s content library, built on a proprietary backend infrastructure, offers defensibility that could be leveraged further with AI to create deeper, more empathetic interactions with patients.

Collaborations with companies like Google, which has been instrumental in helping Elly explore voice-based data collection, and potential partnerships with Samsung to enhance conversational AI, reflect Pooviah’s commitment to leveraging cutting-edge technology. “AI is now able to harness empathy, which is something we are very excited about. That wasn’t possible before,” Pooviah explained.

Policy Recommendations for a Digital Health Future

As Pooviah leads Elly into the future, he is also vocal about the role that public policy should play in fostering health tech innovation. “There’s a movement that’s anti-technology, anti-AI, and very protectionist. We need policies that foster innovation, not stifle it,” he shared, stressing that restrictive policies could hinder technological advancements that are essential for better patient care.

Pooviah pointed out that, while Elly is international, many U.S. government grants exclude immigrant founders like him. “It would be good to be a bit more eligible for grants and support as immigrant founders, especially considering the contributions we make to the U.S. economy,” he suggested.

Pooviah also emphasized the importance of simplifying pathways to FDA approval for digital therapeutics, stating that the process is currently “quite complex and expensive.” Reducing these barriers would allow more companies like Elly to pursue regulatory approval, leading to wider adoption of innovative health technologies.

Role of the Public and Private Sectors

The success of digital health platforms like Elly requires strong collaboration between the public and private sectors. Pooviah believes that governments should not only create favorable policies but also incentivize companies to innovate responsibly. For instance, Australia’s R&D tax incentives have allowed Elly to invest in innovation more freely, and similar policies in the U.S. could accelerate the digital health industry’s growth.

“Having more flexible policies in place, particularly around eligibility for immigrant founders, could create a more supportive environment for startups,” Pooviah noted. By working closely with tech giants like Google, Pfizer, and Apple, Pooviah has demonstrated the immense value of public-private partnerships in scaling digital health solutions. These partnerships not only provide technological support but also open up opportunities for startups to enter new markets and grow sustainably.

Conclusion

Nik Pooviah and Elly are examples of how digital technologies can radically transform healthcare. Their work highlights the necessity of policies that encourage innovation, the importance of strong public-private partnerships, and the potential of AI-driven tools to empower patients. As Elly continues to expand, both in the U.S. and internationally, the future of chronic care management looks brighter—and more compassionate—than ever.

Pooviah leaves us with a thought: “We’re trying to show that AI and digital tools can be a force for good. We just need the right policies and support to make it happen.”